A controversial bill that would expand federal funding for stem-cell research will likely pass the U.S. Senate on Tuesday, setting the stage for President Bush’s first veto.
Swayed by the beleaguered auto supplier’s plea for more time, a federal bankruptcy judge has granted Collins & Aikman an additional two months to file a Chapter 11 plan, allowing the company to retain sole control of its case for a little while longer.
The Federal Communications Commission has approved the sale of Adelphia Communications to Time Warner Inc. and Comcast Corp., on the condition that the cable providers allow competitors access to local sports programming in all markets except for Philadelphia.
Apple Computer Inc. has abandoned its legal effort to find out who at the company leaked trade secrets about an unreleased music interface device, according to recently filed court documents.
In a major victory for Merck & Co. that could save the company millions in future litigation, a New Jersey jury ruled in favor of the pharmaceutical company in the seventh Vioxx case to go to trial.
A U.S. appeals court invalidated for the second time a lower court’s sentencing of former HealthSouth Corp. chief financial officer Michael Martin, saying it was far too lenient for his role in the company’s multi-billion dollar fraud.
For Merck & Co. to successfully defend itself against more than 13,000 lawsuits over the former blockbuster drug Vioxx, the case deliberated Wednesday by a New Jersey jury seems like a must-win.
At Cadence Design Systems Inc., maker of electronic design technologies, corporate life revolves around IP. For the company’s long-time general counsel, Smith McKeithen, that means directing plenty of energy to patent matters while juggling the company’s other legal fronts.
The U.S. Senate voted on Tuesday to make it easier for Americans to have access to cheaper drugs from Canada, a move that is already generating concern within the pharmaceutical industry.
Winn-Dixie Stores Inc. is seeking court approval for a $725 million exit loan it previously negotiated with Wachovia Bank NA, as it tries to emerge from Chapter 11 by the end of October.
With trials over the potential side effects of Merck & Co.’s former blockbuster Vioxx underway, the pharmaceutical giant may soon be headed to court on charges related to its second-biggest seller, Fosamax, in a slew of class action suits that allege the osteoporosis drug could lead to jaw deterioration.
In an aggressive attack to assert its patents related to aminolevulinic acid, Dusa Pharmaceuticals Inc. has shot off a spate of lawsuits against an Arizona chemical supplier and six physicians in multiple states for infringing its patents and, in some cases, engaging in unfair competition and infringing its trademark.
A regional network has followed through on its threat to sue cable giant Comcast Corp. for antitrust violations, seeking $150 million from the company for alleged conflict of interest in business deals and for stunting the reach of its programming.
Former hedge fund manager Kirk Wright, facing numerous charges of mail and securities fraud in connection with missing cash totaling more than $100 million, has pleaded not guilty.
Online fax and messenger service provider Venali Inc. has launched a counterattack against J2 Global Communications Inc., accusing its nemesis of violating federal antitrust, trademark competitiveness and patent laws related to the Internet fax market.
Under fire for the third time in less than a year for its voice over Internet protocol technology, embattled telephone company Vonage Holdings Corp. has been slammed with a patent infringement suit by Klausner Technologies Inc.
The Director of the U.S. Patent and Trademark Office is a defendant in a federal patent suit filed in Virginia by a subsidiary of Farmingdale, N.Y.-based biotech company Enzo Biochem Inc.
Ending a dispute over biotech patents worth millions of dollars, the University of Alabama reached a $25 million settlement this week with biotechnology company Nektar Therapeutics in a case that highlighted the importance of clear rules concerning who owns academic inventions.
The Federal Communications Commission has announced it will soon rule on the $17 billion sale of Adelphia Communications Corp.’s assets to former rivals Comcast Corp. and Time Warner Corp., in the final chapter of what has become a long-running saga.
Not about to mess with its longtime rival’s coveted trade secrets, PepsiCo Inc. pointed authorities towards three people who stole confidential information about Coca-Cola Co.’s recipes and attempted to sell it to Pepsi.